The global Therapeutic Drug Monitoring market size was valued at USD 1856.5 million in 2022 and is forecast to a readjusted size of USD 3271.8 million by 2029 with a CAGR of 8.4% during review period.
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs.
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
Global therapeutic drug monitoring key players include Roche, Danaher and Abbott. The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45 percent. In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.
This report is a detailed and comprehensive analysis for global Therapeutic Drug Monitoring market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Therapeutic Drug Monitoring market size and forecasts, in consumption value ($ Million), 2018-2029
Global Therapeutic Drug Monitoring market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Therapeutic Drug Monitoring market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Therapeutic Drug Monitoring market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Therapeutic Drug Monitoring
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Therapeutic Drug Monitoring market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
Bühlmann Laboratories
Randox Laboratories
Sekisui Medical
Blood Test
Urine Test
Saliva Test
Hospital Labs
Independent Clinical Laboratories
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Strengths:
- Increasing adoption of personalized medicine enhances the demand for therapeutic drug monitoring, enabling optimized patient outcomes.
- Technological advancements in monitoring devices and software improve accuracy and efficiency, driving market growth.
Weaknesses:
- High costs associated with advanced monitoring technologies may limit accessibility for smaller healthcare facilities.
- Lack of standardized guidelines for therapeutic drug monitoring practices can lead to inconsistent implementation across healthcare settings.
Opportunities:
- Growing prevalence of chronic diseases and complex medication regimens creates a need for effective therapeutic drug monitoring solutions.
- Expansion of telemedicine and remote monitoring technologies offers new avenues for enhancing therapeutic drug monitoring services.
Threats:
- Regulatory challenges and varying reimbursement policies may hinder market expansion and innovation.
- Increasing competition from alternative monitoring approaches and technologies can impact market share and pricing strategies.
Political:
- Government healthcare policies and regulations play a significant role in determining reimbursement for therapeutic drug monitoring services, influencing market growth.
- Global political stability and healthcare reforms in emerging markets could drive the expansion of drug monitoring technologies in these regions.
Economic:
- Economic downturns may affect healthcare spending, limiting the adoption of advanced therapeutic drug monitoring systems in cost-sensitive regions.
- Increased healthcare investments, especially in chronic disease management, may fuel market growth for therapeutic drug monitoring solutions.
Social:
- Growing patient awareness and demand for personalized treatments can lead to a higher adoption of therapeutic drug monitoring practices.
- Changing lifestyle patterns and the rising prevalence of chronic diseases drive the need for more effective monitoring solutions.
Technological:
- Advances in sensor technology, artificial intelligence, and data analytics can enhance the accuracy and efficiency of therapeutic drug monitoring systems.
- Integration of cloud-based solutions and mobile apps in therapeutic drug monitoring enables remote patient management, expanding market reach.
Environmental:
- Environmental sustainability concerns may drive the development of eco-friendly monitoring devices and technologies in the healthcare sector.
- Regulations related to electronic waste management may impact the disposal and recycling processes of drug monitoring devices.
Legal:
- Stricter regulations surrounding data privacy and patient confidentiality may influence the design and implementation of therapeutic drug monitoring systems.
- Evolving clinical guidelines and laws regarding drug efficacy and safety could affect the use and adoption of therapeutic drug monitoring technologies.
Suppliers:
- Manufacturers of monitoring devices and diagnostic equipment provide the essential hardware for therapeutic drug monitoring.
- Pharmaceutical companies develop the drugs that require monitoring, driving demand for drug testing and management solutions.
Inputs:
- Data from patient records and medical history is used to inform monitoring and treatment plans for personalized medicine.
- Technological tools like sensors, software, and diagnostic kits are essential inputs for effective therapeutic drug monitoring.
Process:
- Therapeutic drug monitoring involves measuring drug concentrations in the patient’s system and adjusting dosages accordingly.
- Data analytics and AI-powered algorithms optimize dosing adjustments based on real-time monitoring results.
Outputs:
- Personalized drug dosage recommendations based on accurate therapeutic drug monitoring ensure better treatment outcomes.
- Reports on drug levels, potential interactions, and patient progress are delivered to healthcare providers to guide clinical decisions.
Customers:
- Healthcare providers, including hospitals, clinics, and physician offices, use therapeutic drug monitoring to manage patient care.
- Patients undergoing treatment for chronic diseases, organ transplants, or cancer benefit from tailored drug monitoring services to improve therapeutic efficacy.
Threat of New Entrants:
- High capital investment and regulatory requirements create barriers to entry for new companies in the therapeutic drug monitoring market.
- Established market leaders with advanced technologies and strong brand recognition make it difficult for new entrants to gain market share.
Bargaining Power of Suppliers:
- Limited suppliers of advanced diagnostic equipment and monitoring devices give suppliers significant leverage in pricing.
- Pharmaceutical companies providing specific drugs requiring monitoring hold bargaining power in driving demand for drug testing technologies.
Bargaining Power of Buyers:
- Healthcare providers and patients may have limited options, but increasing competition from alternative monitoring solutions can increase buyer leverage.
- Price sensitivity in cost-conscious regions can give healthcare buyers more bargaining power over the cost of therapeutic drug monitoring services.
Threat of Substitutes:
- Alternative drug management strategies, such as genetic testing or other diagnostic approaches, pose a moderate threat to therapeutic drug monitoring services.
- Increasing reliance on digital health tools and wearables could provide substitutes to traditional drug monitoring methods.
Industry Rivalry:
- The market is highly competitive with numerous players offering similar drug monitoring solutions, leading to pricing pressure and continuous innovation.
- Intense competition among existing companies drives constant technological advancements and the development of more efficient monitoring systems.
Raw Materials:
- High-quality sensors and diagnostic components sourced from specialized suppliers are essential for developing accurate drug monitoring systems.
- Advanced software and data analytics platforms are critical components for interpreting and managing patient data in therapeutic drug monitoring.
Technology:
- Ongoing advancements in sensor technology, AI, and machine learning contribute to the development of more precise and automated monitoring devices.
- The integration of cloud-based solutions and telemedicine capabilities enhances the ability to monitor patients remotely, driving the evolution of therapeutic drug monitoring technologies.
Regulatory Environment:
- Strict regulatory standards for medical devices and software ensure the safety and efficacy of therapeutic drug monitoring systems, impacting manufacturers’ ability to enter the market.
- Compliance with data privacy and security regulations (such as HIPAA) is a key factor for companies developing digital drug monitoring solutions.
Manufacturers:
- Companies specializing in medical devices and diagnostic tools play a crucial role in producing advanced therapeutic drug monitoring systems for healthcare providers.
- Pharmaceutical manufacturers contribute to the market by producing drugs that require therapeutic drug monitoring, creating continuous demand for monitoring technologies.
Distributors:
- Medical equipment distributors are essential for ensuring the availability of therapeutic drug monitoring devices to hospitals, clinics, and laboratories.
- Healthcare distribution networks help bring software and remote monitoring solutions to clinicians, facilitating wider adoption of drug monitoring systems.
Service Providers:
- Healthcare institutions and laboratories provide diagnostic and monitoring services, using therapeutic drug monitoring technologies to manage patient treatment.
- Telehealth platforms and remote patient monitoring services enhance access to therapeutic drug monitoring, particularly in rural or underserved areas.
End Users:
- Hospitals and clinics are primary users of therapeutic drug monitoring systems, utilizing them for personalized medicine and to optimize drug dosing for patients.
- Patients, particularly those with chronic conditions or undergoing treatments like chemotherapy or organ transplants, are direct beneficiaries of personalized therapeutic drug monitoring.
Market Demand:
- Increased demand for precision medicine, driven by the rise in chronic diseases and complex therapeutic regimens, fuels the need for more widespread therapeutic drug monitoring.
- Growing focus on patient safety and optimal drug efficacy, particularly in high-risk treatments, leads to higher adoption rates of drug monitoring technologies among healthcare providers.
Chapter 1, to describe Therapeutic Drug Monitoring product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Drug Monitoring, with revenue, gross margin and global market share of Therapeutic Drug Monitoring from 2018 to 2023.
Chapter 3, the Therapeutic Drug Monitoring competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Drug Monitoring market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Drug Monitoring.
Chapter 13, to describe Therapeutic Drug Monitoring research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Therapeutic Drug Monitoring
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Therapeutic Drug Monitoring by Type
1.3.1 Overview: Global Therapeutic Drug Monitoring Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Therapeutic Drug Monitoring Consumption Value Market Share by Type in 2022
1.3.3 Blood Test
1.3.4 Urine Test
1.3.5 Saliva Test
1.4 Global Therapeutic Drug Monitoring Market by Application
1.4.1 Overview: Global Therapeutic Drug Monitoring Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Labs
1.4.3 Independent Clinical Laboratories
1.4.4 Others
1.5 Global Therapeutic Drug Monitoring Market Size & Forecast
1.6 Global Therapeutic Drug Monitoring Market Size and Forecast by Region
1.6.1 Global Therapeutic Drug Monitoring Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Therapeutic Drug Monitoring Market Size by Region, (2018-2029)
1.6.3 North America Therapeutic Drug Monitoring Market Size and Prospect (2018-2029)
1.6.4 Europe Therapeutic Drug Monitoring Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Therapeutic Drug Monitoring Market Size and Prospect (2018-2029)
1.6.6 South America Therapeutic Drug Monitoring Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Therapeutic Drug Monitoring Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Therapeutic Drug Monitoring Product and Solutions
2.1.4 Roche Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher Therapeutic Drug Monitoring Product and Solutions
2.2.4 Danaher Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Danaher Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Therapeutic Drug Monitoring Product and Solutions
2.3.4 Abbott Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Product and Solutions
2.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Siemens Healthineers
2.5.1 Siemens Healthineers Details
2.5.2 Siemens Healthineers Major Business
2.5.3 Siemens Healthineers Therapeutic Drug Monitoring Product and Solutions
2.5.4 Siemens Healthineers Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Siemens Healthineers Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Product and Solutions
2.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 bioMerieux
2.7.1 bioMerieux Details
2.7.2 bioMerieux Major Business
2.7.3 bioMerieux Therapeutic Drug Monitoring Product and Solutions
2.7.4 bioMerieux Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 bioMerieux Recent Developments and Future Plans
2.8 Bühlmann Laboratories
2.8.1 Bühlmann Laboratories Details
2.8.2 Bühlmann Laboratories Major Business
2.8.3 Bühlmann Laboratories Therapeutic Drug Monitoring Product and Solutions
2.8.4 Bühlmann Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bühlmann Laboratories Recent Developments and Future Plans
2.9 Randox Laboratories
2.9.1 Randox Laboratories Details
2.9.2 Randox Laboratories Major Business
2.9.3 Randox Laboratories Therapeutic Drug Monitoring Product and Solutions
2.9.4 Randox Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Randox Laboratories Recent Developments and Future Plans
2.10 Sekisui Medical
2.10.1 Sekisui Medical Details
2.10.2 Sekisui Medical Major Business
2.10.3 Sekisui Medical Therapeutic Drug Monitoring Product and Solutions
2.10.4 Sekisui Medical Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sekisui Medical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Therapeutic Drug Monitoring Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Therapeutic Drug Monitoring by Company Revenue
3.2.2 Top 3 Therapeutic Drug Monitoring Players Market Share in 2022
3.2.3 Top 6 Therapeutic Drug Monitoring Players Market Share in 2022
3.3 Therapeutic Drug Monitoring Market: Overall Company Footprint Analysis
3.3.1 Therapeutic Drug Monitoring Market: Region Footprint
3.3.2 Therapeutic Drug Monitoring Market: Company Product Type Footprint
3.3.3 Therapeutic Drug Monitoring Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Therapeutic Drug Monitoring Consumption Value and Market Share by Type (2018-2023)
4.2 Global Therapeutic Drug Monitoring Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Therapeutic Drug Monitoring Consumption Value Market Share by Application (2018-2023)
5.2 Global Therapeutic Drug Monitoring Market Forecast by Application (2024-2029)
6 North America
6.1 North America Therapeutic Drug Monitoring Consumption Value by Type (2018-2029)
6.2 North America Therapeutic Drug Monitoring Consumption Value by Application (2018-2029)
6.3 North America Therapeutic Drug Monitoring Market Size by Country
6.3.1 North America Therapeutic Drug Monitoring Consumption Value by Country (2018-2029)
6.3.2 United States Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
6.3.3 Canada Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
6.3.4 Mexico Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Therapeutic Drug Monitoring Consumption Value by Type (2018-2029)
7.2 Europe Therapeutic Drug Monitoring Consumption Value by Application (2018-2029)
7.3 Europe Therapeutic Drug Monitoring Market Size by Country
7.3.1 Europe Therapeutic Drug Monitoring Consumption Value by Country (2018-2029)
7.3.2 Germany Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
7.3.3 France Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
7.3.5 Russia Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
7.3.6 Italy Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region
8.3.1 Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Region (2018-2029)
8.3.2 China Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
8.3.3 Japan Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
8.3.4 South Korea Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
8.3.5 India Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
8.3.7 Australia Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
9 South America
9.1 South America Therapeutic Drug Monitoring Consumption Value by Type (2018-2029)
9.2 South America Therapeutic Drug Monitoring Consumption Value by Application (2018-2029)
9.3 South America Therapeutic Drug Monitoring Market Size by Country
9.3.1 South America Therapeutic Drug Monitoring Consumption Value by Country (2018-2029)
9.3.2 Brazil Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
9.3.3 Argentina Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country
10.3.1 Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Country (2018-2029)
10.3.2 Turkey Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
10.3.4 UAE Therapeutic Drug Monitoring Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Therapeutic Drug Monitoring Market Drivers
11.2 Therapeutic Drug Monitoring Market Restraints
11.3 Therapeutic Drug Monitoring Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Therapeutic Drug Monitoring Industry Chain
12.2 Therapeutic Drug Monitoring Upstream Analysis
12.3 Therapeutic Drug Monitoring Midstream Analysis
12.4 Therapeutic Drug Monitoring Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Therapeutic Drug Monitoring Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Therapeutic Drug Monitoring Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Therapeutic Drug Monitoring Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Therapeutic Drug Monitoring Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Therapeutic Drug Monitoring Product and Solutions
Table 8. Roche Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Danaher Company Information, Head Office, and Major Competitors
Table 11. Danaher Major Business
Table 12. Danaher Therapeutic Drug Monitoring Product and Solutions
Table 13. Danaher Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Danaher Recent Developments and Future Plans
Table 15. Abbott Company Information, Head Office, and Major Competitors
Table 16. Abbott Major Business
Table 17. Abbott Therapeutic Drug Monitoring Product and Solutions
Table 18. Abbott Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Abbott Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Therapeutic Drug Monitoring Product and Solutions
Table 23. Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 26. Siemens Healthineers Major Business
Table 27. Siemens Healthineers Therapeutic Drug Monitoring Product and Solutions
Table 28. Siemens Healthineers Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Siemens Healthineers Recent Developments and Future Plans
Table 30. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Therapeutic Drug Monitoring Product and Solutions
Table 33. Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bio-Rad Laboratories Recent Developments and Future Plans
Table 35. bioMerieux Company Information, Head Office, and Major Competitors
Table 36. bioMerieux Major Business
Table 37. bioMerieux Therapeutic Drug Monitoring Product and Solutions
Table 38. bioMerieux Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. bioMerieux Recent Developments and Future Plans
Table 40. Bühlmann Laboratories Company Information, Head Office, and Major Competitors
Table 41. Bühlmann Laboratories Major Business
Table 42. Bühlmann Laboratories Therapeutic Drug Monitoring Product and Solutions
Table 43. Bühlmann Laboratories Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bühlmann Laboratories Recent Developments and Future Plans
Table 45. Randox Laboratories Company Information, Head Office, and Major Competitors
Table 46. Randox Laboratories Major Business
Table 47. Randox Laboratories Therapeutic Drug Monitoring Product and Solutions
Table 48. Randox Laboratories Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Randox Laboratories Recent Developments and Future Plans
Table 50. Sekisui Medical Company Information, Head Office, and Major Competitors
Table 51. Sekisui Medical Major Business
Table 52. Sekisui Medical Therapeutic Drug Monitoring Product and Solutions
Table 53. Sekisui Medical Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Sekisui Medical Recent Developments and Future Plans
Table 55. Global Therapeutic Drug Monitoring Revenue (USD Million) by Players (2018-2023)
Table 56. Global Therapeutic Drug Monitoring Revenue Share by Players (2018-2023)
Table 57. Breakdown of Therapeutic Drug Monitoring by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Therapeutic Drug Monitoring, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Therapeutic Drug Monitoring Players
Table 60. Therapeutic Drug Monitoring Market: Company Product Type Footprint
Table 61. Therapeutic Drug Monitoring Market: Company Product Application Footprint
Table 62. Therapeutic Drug Monitoring New Market Entrants and Barriers to Market Entry
Table 63. Therapeutic Drug Monitoring Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Therapeutic Drug Monitoring Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Therapeutic Drug Monitoring Consumption Value Share by Type (2018-2023)
Table 66. Global Therapeutic Drug Monitoring Consumption Value Forecast by Type (2024-2029)
Table 67. Global Therapeutic Drug Monitoring Consumption Value by Application (2018-2023)
Table 68. Global Therapeutic Drug Monitoring Consumption Value Forecast by Application (2024-2029)
Table 69. North America Therapeutic Drug Monitoring Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Therapeutic Drug Monitoring Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Therapeutic Drug Monitoring Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Therapeutic Drug Monitoring Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Therapeutic Drug Monitoring Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Therapeutic Drug Monitoring Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Therapeutic Drug Monitoring Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Therapeutic Drug Monitoring Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Therapeutic Drug Monitoring Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Therapeutic Drug Monitoring Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Therapeutic Drug Monitoring Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Therapeutic Drug Monitoring Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Therapeutic Drug Monitoring Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Therapeutic Drug Monitoring Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Therapeutic Drug Monitoring Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Therapeutic Drug Monitoring Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Therapeutic Drug Monitoring Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Therapeutic Drug Monitoring Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Therapeutic Drug Monitoring Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Therapeutic Drug Monitoring Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Therapeutic Drug Monitoring Raw Material
Table 100. Key Suppliers of Therapeutic Drug Monitoring Raw Materials
List of Figures
Figure 1. Therapeutic Drug Monitoring Picture
Figure 2. Global Therapeutic Drug Monitoring Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Therapeutic Drug Monitoring Consumption Value Market Share by Type in 2022
Figure 4. Blood Test
Figure 5. Urine Test
Figure 6. Saliva Test
Figure 7. Global Therapeutic Drug Monitoring Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Therapeutic Drug Monitoring Consumption Value Market Share by Application in 2022
Figure 9. Hospital Labs Picture
Figure 10. Independent Clinical Laboratories Picture
Figure 11. Others Picture
Figure 12. Global Therapeutic Drug Monitoring Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Therapeutic Drug Monitoring Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Therapeutic Drug Monitoring Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Therapeutic Drug Monitoring Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Therapeutic Drug Monitoring Consumption Value Market Share by Region in 2022
Figure 17. North America Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Therapeutic Drug Monitoring Revenue Share by Players in 2022
Figure 23. Therapeutic Drug Monitoring Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Therapeutic Drug Monitoring Market Share in 2022
Figure 25. Global Top 6 Players Therapeutic Drug Monitoring Market Share in 2022
Figure 26. Global Therapeutic Drug Monitoring Consumption Value Share by Type (2018-2023)
Figure 27. Global Therapeutic Drug Monitoring Market Share Forecast by Type (2024-2029)
Figure 28. Global Therapeutic Drug Monitoring Consumption Value Share by Application (2018-2023)
Figure 29. Global Therapeutic Drug Monitoring Market Share Forecast by Application (2024-2029)
Figure 30. North America Therapeutic Drug Monitoring Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Therapeutic Drug Monitoring Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Therapeutic Drug Monitoring Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Therapeutic Drug Monitoring Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Therapeutic Drug Monitoring Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Therapeutic Drug Monitoring Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 40. France Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Therapeutic Drug Monitoring Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Therapeutic Drug Monitoring Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Therapeutic Drug Monitoring Consumption Value Market Share by Region (2018-2029)
Figure 47. China Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 50. India Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Therapeutic Drug Monitoring Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Therapeutic Drug Monitoring Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Therapeutic Drug Monitoring Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Therapeutic Drug Monitoring Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Therapeutic Drug Monitoring Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Therapeutic Drug Monitoring Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Therapeutic Drug Monitoring Consumption Value (2018-2029) & (USD Million)
Figure 64. Therapeutic Drug Monitoring Market Drivers
Figure 65. Therapeutic Drug Monitoring Market Restraints
Figure 66. Therapeutic Drug Monitoring Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Therapeutic Drug Monitoring in 2022
Figure 69. Manufacturing Process Analysis of Therapeutic Drug Monitoring
Figure 70. Therapeutic Drug Monitoring Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
